GoHealth (NASDAQ:GOCO) Stock Price Down 1.2% – What’s Next?

GoHealth, Inc. (NASDAQ:GOCOGet Free Report) shares were down 1.2% during mid-day trading on Monday . The stock traded as low as $2.36 and last traded at $2.37. Approximately 35,917 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 70,720 shares. The stock had previously closed at $2.40.

Analysts Set New Price Targets

Several research firms have recently commented on GOCO. Royal Bank Of Canada reduced their target price on shares of GoHealth from $12.00 to $5.00 and set a “sector perform” rating for the company in a research note on Wednesday, November 26th. William Blair reissued a “market perform” rating on shares of GoHealth in a report on Wednesday, November 19th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of GoHealth in a research report on Monday, December 29th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $5.00.

Check Out Our Latest Analysis on GOCO

GoHealth Price Performance

The company has a debt-to-equity ratio of 2.64, a quick ratio of 1.64 and a current ratio of 1.64. The stock’s fifty day moving average price is $2.89 and its 200-day moving average price is $4.44. The firm has a market cap of $68.05 million, a PE ratio of -0.15 and a beta of 1.64.

GoHealth (NASDAQ:GOCOGet Free Report) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($2.06) by $1.87. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. The firm had revenue of $34.19 million for the quarter, compared to the consensus estimate of $102.36 million. As a group, equities analysts forecast that GoHealth, Inc. will post -5.5 EPS for the current fiscal year.

Hedge Funds Weigh In On GoHealth

Hedge funds and other institutional investors have recently bought and sold shares of the company. Public Sector Pension Investment Board acquired a new stake in GoHealth in the third quarter valued at $8,100,000. Redwood Capital Management LLC acquired a new position in shares of GoHealth during the 3rd quarter worth $4,455,000. Corient Private Wealth LLC boosted its position in shares of GoHealth by 7.7% in the 2nd quarter. Corient Private Wealth LLC now owns 125,938 shares of the company’s stock worth $699,000 after buying an additional 8,979 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of GoHealth by 4.3% in the 2nd quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock worth $660,000 after buying an additional 4,955 shares in the last quarter. Finally, Focus Partners Wealth purchased a new position in GoHealth during the 3rd quarter valued at about $270,000. 24.21% of the stock is owned by institutional investors and hedge funds.

About GoHealth

(Get Free Report)

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.

Featured Stories

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.